We fight to improve the lives
of everyone affected by epilepsy

Stories about epilepsy medicines

Some epilepsy medicines “cannot be stockpiled”, NHS list reveals

9 Apr 2019

On 3 April, BBC Newsnight reported that some medicines, including some for epilepsy, bipolar disorder and neuropathic pain, cannot be stockpiled.

This comes after the Health Secretary Matthew Hancock said in parliament that medical suppliers had been asked to stockpile an extra six-weeks’ worth of medicines. This is to ensure medicine supply continues in all Brexit scenarios.

Topiramate may be linked to increased risk of birth defects in babies born to women taking the medicine

9 Jan 2018

TopirimateA new US study has found that taking the medicine topiramate during pregnancy may cause an increased risk of birth defects.

Topiramate is an epilepsy medicine sometimes used to treat generalised tonic-clonic seizures or focal seizures. This medicine can also be used for other conditions, such as bipolar disorder.

Government update to guidelines about switching between different forms of epilepsy medicines says prescribers should consider the individual’s concerns

1 Dec 2017

The government has added to its guidelines about switching between different forms of epilepsy medicines. The update says that prescribers need to take into consideration people’s thoughts and concerns.

Zarontin syrup discontinued

13 Apr 2017

The medicine company Pfizer has stopped making its version of ethosuximide syrup, called Zarontin.

If you take Zarontin, you will need to switch to a different manufacturer’s version of ethosuximide syrup.

If you have any concerns about this, speak to your doctor, epilepsy nurse or pharmacist.


Subscribe to epilepsy medicines